Skip to main content

Table 3 Anthropometric characteristics and serum hormone concentrations in women with different genotypes

From: Association between ACEgene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls

ACE genetype

PCOS

 

CONTROL

 
 

DD

ID

II

P

DD

ID

II

P

N

98

160

88

_

77

107

52

0.458a

Frequency (%)

28.32

46.24

25.43

 

32.63

45.34

22.03

 

Age (years)

26.63 ± 3.86

26.31 ± 4.16

26.93 ± 3.69

0.75

32.62 ± 3.43

31.63 ± 4.45

31.15 ± 4.66

0.38

AAM (years)

14.43 ± 1.77

14.66 ± 1.61

14.44 ± 1.45

0.67

15.23 ± 3.73

14.59 ± 1.52

14.63 ± 2.76

0.58

BMI (kg/m2)

22.12 ± 3.23

23.15 ± 4.02

22.55 ± 3.66

0.33

20.75 ± 2.06

21.49 ± 2.46

21.48 ± 2.33

0.37

FSH (IU/L)

8.22 ± 5.00

(N = 92)

7.91 ± 4.5

(N = 151)

8.83 ± 10.25

(N = 83)

0.77

6.7 ± 2.87

(N = 72)

7.52 ± 2.3

(N = 99)

6.67 ± 1.49

(N = 48)

0.13

LH (IU/L)

20.94 ± 21.53

(N = 92)

21.98 ± 22

(N = 151)

13.96 ± 7.33

(N = 83)

0.19

4.68 ± 2.57

(N = 72)

4.77 ± 1.94

(N = 99)

4.31 ± 2.12

(N = 48)

0.55

LH/FSH

2.75 ± 1.6

(N = 92)

2.78 ± 1.26

(N = 151)

1.93 ± 0.88

(N = 83)

0.01

0.73 ± 0.34

(N = 72)

0.68 ± 0.37

(N = 99)

0.65 ± 0.3

(N = 48)

0.66

T* (nMol/L)

2.90 ± 1.11

(N = 92)

3.01 ± 1.32

(N = 151)

2.11 ± 0.9

(N = 83)

0.0045

1.62 ± 1.01

(N = 72)

1.03 ± 0.73

(N = 99)

1.11 ± 0.53

(N = 48)

0.0052

E2 (pMol/L)

259.7 ± 128.72

(N = 92)

223.49 ± 109.96

(N = 151)

190.46 ± 114.8

(N = 83)

0.053

191.52 ± 152.71

(N = 72)

189.84 ± 176.82

(N = 99)

147.35 ± 93.67

(N = 48)

0.25

  1. Note: a: P = 0.458, genotypic distributions in women with PCOS vs those in the controls.
  2. P* = 0.0001 (the total T values of women with PCOS vs those of controls) We failed to assay the hormone levels in several women with PCOS and controls.